abstract |
The invention relates to an N-benzenesulfonylbenzamide compound represented by formula (I), or a crystalline form, a prodrug, a pharmaceutically acceptable salt, a stereoisomer, a solvate or a hydrate thereof, a pharmaceutical composition comprising same, and its use as a Bcl-2 protein inhibitor for the preparation of a medicament for the treatment of leukemia or cancer. |